Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
64 participants
INTERVENTIONAL
2017-05-01
2021-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Longitudinal Study of the Default-mode Network Connectivity in Brain Injured Patients Recovering From Coma
NCT01620957
Investigating Electroencephalographic Predictors of Default Mode Network Anticorrelation in Healthy Adults
NCT05592600
Early Cognitive Impairment in Multiple Sclerosis
NCT01157728
MRI Hippocampal Microstructure and Episodic Memory in Early Multiple Sclerosis
NCT03692975
Influence of Emotional Disorders and Executive on the Components Retrograde and Anterograde Episodic Memory in MS
NCT02518776
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
In this study, investigators aim to evaluate connectivity regardless whether patients present a clinical type that requires medical treatment. In this point, patients with progressive evolution as well as initial forms of the disease (CIS) will be included and properly established forms of MS in RR forms. Researchers will not focus on medical treatment as some of these clinical forms have no indication for disease modifying drugs. Nevertheless, investigators consider that the study of connectivity is worth regardless their pharmacological treatment.
The investigators also aim to offer data on the natural history of MS evolution for distinct MS type patients and healthy controls, as this study is planned to collect data longitudinally.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
PARALLEL
OTHER
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Clinical measures
MS patients recruited for this study will complete a resting state functional magnetic resonance image (rs-fMRI) session that will provide information on how DMN network works for each group and all MS patients will also complete a comprehensive neuropsychological battery including cognitive and behavioural tests of interest in MS
neuropsychological battery
neuropsychological battery including cognitive and behavioural tests
resting state functional magnetic resonance image (rs-fMRI)
rs-fMRI
Control measures
Healthy participants recruited for this study will complete a resting state functional magnetic resonance image (rs-fMRI) session that will provide information on how DMN network works
resting state functional magnetic resonance image (rs-fMRI)
rs-fMRI
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
neuropsychological battery
neuropsychological battery including cognitive and behavioural tests
resting state functional magnetic resonance image (rs-fMRI)
rs-fMRI
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* 18 to 60 years old.
* Consent form signature.
Exclusion Criteria
* Mayor psychiatric illness.
* Physical or intellectual limitations to successfully perform - neuropsychological evaluation.
* Any other circumstance that may interfere with functional magnetic resonance session.
* Abnormal renal function previous to magnetic resonance image (MRI) session.
18 Years
60 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Hospital General Universitario Gregorio Marañon
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
María Luisa Martinez Gines
neurologist
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
María Luisa Martínez-Ginés, MD
Role: PRINCIPAL_INVESTIGATOR
Hospital General Universitario Gregorio Marañón
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Hospital General Universitario Gregorio Marañón
Madrid, , Spain
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CONNECT-15
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.